Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance? | Zendy

Roya Vahedi-Shahandashti | Zendy; AnnaMaria Dietl | Zendy; Ulrike Binder | Zendy; Markus Nagl | Zendy; Reinhard Würzner | Zendy; Cornelia LassFlörl | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?

Author(s) -

Roya Vahedi-Shahandashti,

AnnaMaria Dietl,

Ulrike Binder,

Markus Nagl,

Reinhard Würzner,

Cornelia LassFlörl

Publication year - 2022

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02274-21

Subject(s) - aspergillus terreus , amphotericin b , biology , microbiology and biotechnology , galleria mellonella , population , aspergillus , aspergillosis , fungicide , virulence , antifungal , immunology , medicine , genetics , botany , environmental health , gene

Aspergillus terreus is an opportunistic causative agent of invasive aspergillosis and, in most cases, it is refractory to amphotericin B (AMB) therapy. Notably, AMB-susceptibleAspergillus terreus sensu stricto (s.s.) representatives exist which are also associated with poor clinical outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research